Cardiology - European Medical Journal

Continue

Cardiology

Articles
8 Mins
14th October 2022

Underdiagnosis and Poor Adherence Are Contributing to Rising Cases of Hypertension

Essential hypertension, a significant risk factor for cardiovascular diseases (CVD), kidney failure, and all-cause mortality, is largely reversible with lifestyle changes and highly efficacious medications. However, the prevalence of raised blood pressure (BP) is increasing globally. Considering its lack of symptoms, many people remain undiagnosed and unaware of the risks. In addition, a lack of perceived benefit makes adhering to pharmacological and non-pharmacological interventions challenging for patients.
EMJ Cardiology 10.1 2022 Feature Image
8 Mins
6th October 2022

Effect of Age on the Abdominal Aortic Aneurysm: Fuzzy Logic Analysis

The aneurysm refers to the increase in arterial diameter in a localised position and this is characterised by the non-parallelism of the arterial wall. Despite prediction models trying to anticipate the onset of an aneurysm, the limits of their accuracy are often reached.
5 Mins
3rd October 2022

Rare Association of Takotsubo Cardiomyopathy with Acquired Bartter-Like Phenotype and Colonic Stricture

Takotsubo syndrome (TTS), also known as stress-related cardiomyopathy or apical ballooning, is a transient systolic and diastolic dysfunction that is often preceded by some physical or emotional triggers. First described in Japan in 1990, it is derived from a Japanese word meaning ‘octopus pot’.
13 Mins
15th September 2022

Heated Tobacco Products and Cardiovascular Disease: A Narrative Review of Peer-Reviewed Publications

This article discussed cigarette smoking as a major risk factor for cardiovascular disease (CVD). Looking through the lens of toxic cigarette smoke constituents, the review described the oxidative stress and inflammatory responses induced following their entry into the bloodstream.
11 Mins
8th September 2022

Efficacy and Safety of Aficamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Highlighting a presentation that took place as part of the European Society of Cardiology’s (ESC) Heart Failure 2022 congress, this article summarised data on the efficacy and safety of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).
7 Mins
26th August 2022

The Clock Is Ticking: The Imminent Need to Re-evaluate the Standard of Care in the 90-Day High-Risk Post-Acute Myocardial Infarction Period
12 Mins
15th August 2022

Interview: Alexander E Berezin

EMJ had the pleasure of interviewing Alexander E Berezin, Fellow of the European Society of Cardiology (ESC) on his research in cardiology…
Feature Image Cardio Supp 3
18 Mins
21st July 2022

Personalised Approach to Atherosclerotic Cardiovascular Disease: The Future is Here

This plenary session began with a focus on cutting edge research into the role of the immune system in atherosclerotic cardiovascular dise…